Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jan 25 | MSCI MSCI | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 549.83 | 29,564 | 16.26 mm | 29,564 |
31 Dec 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 24.9416 | 1,503 | 37.49 k | 55,505 |
5 Dec 24 | MSCI MSCI | Common Stock | Buy | Acquire P | Yes | No | 614.08 | 493 | 302.74 k | 330,379 |
5 Dec 24 | MSCI MSCI | Common Stock | Buy | Acquire P | Yes | No | 613.38 | 1,807 | 1.11 mm | 329,886 |
5 Dec 24 | MSCI MSCI | Common Stock | Buy | Acquire P | Yes | No | 610 | 600 | 366.00 k | 328,079 |
30 Sep 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 27.9249 | 1,342 | 37.48 k | 54,002 |
28 Jun 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 26.7998 | 1,399 | 37.49 k | 52,660 |